Evaluation of Substituted N,N′-Diarylsulfonamides as Activators of the Tumor Cell Specific M2 Isoform of Pyruvate Kinase
- 17 December 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (3) , 1048-1055
Abstract
The metabolism of cancer cells is altered to support rapid proliferation. Pharmacological activators of a tumor cell specific pyruvate kinase isozyme (PKM2) may be an approach for altering the classic Warburg effect characteristic of aberrant metabolism in cancer cells yielding a novel antiproliferation strategy. In this manuscript, we detail the discovery of a series of substituted N,N′-diarylsulfonamides as activators of PKM2. The synthesis of numerous analogues and the evaluation of structure−activity relationships are presented as well as assessments of mechanism and selectivity. Several agents are found that have good potencies and appropriate solubility for use as chemical probes of PKM2 including 55 (AC50 = 43 nM, maximum response = 84%; solubility = 7.3 μg/mL), 56 (AC50 = 99 nM, maximum response = 84%; solubility = 5.7 μg/mL), and 58 (AC50 = 38 nM, maximum response = 82%; solubility = 51.2 μg/mL). The small molecules described here represent first-in-class activators of PKM2Keywords
This publication has 26 references indexed in Scilit:
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Identification of Pregnane X Receptor Ligands Using Time-Resolved Fluorescence Resonance Energy Transfer and Quantitative High-Throughput ScreeningASSAY and Drug Development Technologies, 2009
- A Basis for Reduced Chemical Library Inhibition of Firefly Luciferase Obtained from Directed EvolutionJournal of Medicinal Chemistry, 2009
- Brick by brick: metabolism and tumor cell growthCurrent Opinion in Genetics & Development, 2008
- Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical librariesProceedings of the National Academy of Sciences, 2006
- Nanoliter Dispensing for uHTS Using Pin ToolsASSAY and Drug Development Technologies, 2005
- Identification of Kinase Inhibitors By An ATP Depletion MethodASSAY and Drug Development Technologies, 2004
- The putative effector‐binding site of Leishmania mexicana pyruvate kinase studied by site‐directed mutagenesisFEBS Letters, 2002
- Regulation of Pyruvate Kinase M Gene ExpressionBiochemical and Biophysical Research Communications, 1999
- On the Origin of Cancer CellsScience, 1956